As courts reject inflated medical bills, a new standard is emerging. This article explores how Sanchez and Cuevas are reshaping expert testimony—and why Fair Market Value is fast becoming the credible path forward in valuing medical damages.
As courts reject inflated medical bills, a new standard is emerging. This article explores how Sanchez and Cuevas are reshaping expert testimony—and why Fair Market Value is fast becoming the credible path forward in valuing medical damages.